Acuta Capital Partners’s Alexion Pharmaceuticals Inc ALXN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-15,000
Closed -$2.1M 67
2017
Q3
$2.1M Buy
+15,000
New +$2.1M 0.38% 26